伴侶動物耳部感染治療市場 - 按藥物類型、動物類型、藥物類型、給藥方式、疾病類型、配銷通路- 全球預測 2024 - 2032

Companion Animal Ear Infection Treatment Market - By Drug Type, Animal Type, Medication Type, Mode of Administration, Disease Type, Distribution Channel - Global Forecast 2024 - 2032

出版日期: 2024年03月01日 | 出版商:

Global Market Insights Inc. | 英文 215 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

由於狗和貓等伴侶動物耳部感染盛行率不斷上升，2024年至2032年間伴侶動物耳部感染治療市場規模的複合年成長率可能為6.8%。根據美國養犬俱樂部的數據，大約 20% 的狗患有某種形式的耳部疾病，可能會影響一隻或兩隻耳朵。環境過敏原、耳蟎、細菌或酵母菌過度生長以及解剖學傾向等耳部感染數量的增加將隨後推動市場成長。

此外，獸醫技術的進步促進了伴侶動物耳部感染創新治療方案的發展。這些進步包括引入新型藥物傳輸系統，例如長效滴耳劑和局部製劑，可提高治療效果和患者依從性。寵物醫療保健產業的擴張，加上伴侶動物的日益普及，特別是在城市地區，將進一步促進該產業的擴張。

伴侶動物耳部感染治療產業根據藥物類型、動物類型、藥物類型、給藥方式、疾病類型、配銷通路和地區進行細分。

從給藥方式來看，由於口服藥物的便利性和有效性，預計到 2032 年，口服藥物的市場規模複合年成長率將達到 6.8%。口服抗生素和抗真菌藥物提供了一種對抗感染的系統方法，可到達僅透過局部治療難以到達的耳道區域。此外，獸藥的進步促進了口服藥物的開發，其安全性和適口性得到改善，從而提高了患者的依從性和治療成功率。

伴侶動物耳部感染治療產業的藥局配銷通路部分預計在 2024 年至 2032 年期間複合年成長率為 6.9%。寵物擁有率的提高和對寵物醫療保健的認知的提高將推動對耳部感染等常見疾病的便捷且可及的治療方案的需求。在藥局購買耳部感染治療藥物和其他寵物護理產品的便利性進一步吸引了尋求快速且經濟高效的解決方案來管理寵物健康的寵物主人。

由於嚴格的寵物醫療保健標準法規以及對預防性獸醫護理的日益重視，歐洲伴侶動物耳部感染治療行業規模在 2024 年至 2032 年間將實現 6.8% 的複合年成長率。德國、法國和英國等國家的寵物擁有率較高，加上寵物主人可支配收入的不斷成長，將創造有利的市場環境。此外，獸醫學的進步，包括提供專門的耳部感染治療產品和提高治療效果的診斷工具，將推動區域市場的成長。

主要動向：按地區
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 歐洲其他地區
亞太地區
- 日本
- 中國
- 印度
- 澳洲
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 中東和非洲其他地區

第 12 章：公司簡介

Bayer AG
Ceva Sante Animale
Dechra Pharmaceuticals PLC
Elanco Animal Health Incorporated
Entod International
Merck & Co., Inc.
Nextmune
Penn Veterinary Supply, Inc.
Piedmont Animal Health, Inc.
Vedco, Inc.
Vetnique Labs
Vetoquinol S.A.
Virbac S.A.
Wedgewood Village Pharmacy, LLC
Zoetis Inc.

簡介目錄

Product Code: 8373

Companion animal ear infection treatment market size is likely to register 6.8% CAGR between 2024 to 2032, driven by the increasing prevalence of ear infections among companion animals, such as dogs and cats. As per American Kennel Club, around 20% dogs have some form of ear disease, which could affect one or both ears. The rising count of ear infections including environmental allergens, ear mites, bacterial or yeast overgrowth, and anatomical predispositions will subsequently boost the market growth.

Moreover, technological advancements in veterinary medicine have led to the development of innovative treatment options for companion animal ear infections. These advancements include the introduction of novel drug delivery systems, such as long-acting ear drops and topical formulations, which enhance treatment efficacy and patient compliance. The expansion of the pet healthcare sector, coupled with the increasing adoption of companion animals, particularly in urban areas, will further contribute to the industry expansion.

The companion animal ear infection treatment industry is segmented based on drug type, animal type, medication type, mode of administration, disease type, distribution channel and region.

By mode of administration, the market size from the oral segment is anticipated to witness 6.8% CAGR through 2032, attributed to the convenience and efficacy of oral medications. Oral antibiotics and antifungal medications offer a systemic approach to combating infections, reaching areas of the ear canal that may be difficult to access with topical treatments alone. Additionally, advancements in veterinary pharmaceuticals have led to the development of oral medications with improved safety profiles and palatability for increasing patient compliance and treatment success rates.

The drug store distribution channel segment in the companion animal ear infection treatment industry is estimated to strike 6.9% CAGR during 2024-2032. Increasing pet ownership rates and awareness about pet healthcare will drive the demand for convenient and accessible treatment options for common ailments like ear infections. The convenience of purchasing ear infection treatments alongside other pet care products at drug stores is further appealing to pet owners seeking quick and cost-effective solutions to manage the health of their pets.

Europe companion animal ear infection treatment industry size will record 6.8% CAGR between 2024-2032, attributed to stringent regulations governing pet healthcare standards and the increasing emphasis on preventive veterinary care. The high pet ownership rates in countries like Germany, France, and the U.K., coupled with the growing disposable income of pet owners will foster a conducive market environment. Furthermore, advancements in veterinary medicine, including the availability of specialized ear infection treatment products and diagnostic tools to enhance the efficacy of treatment will drive regional the market growth.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
- 1.6.1 Primary
- 1.6.2 Secondary
  - 1.6.2.1 Paid sources
  - 1.6.2.2 Public sources

Chapter 2 Executive Summary

2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing rate of pet ownership globally
  - 3.2.1.2 Growing advancements in veterinary medicine
  - 3.2.1.3 Rising prevalence of ear infections among pets
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Lack of compliance
  - 3.2.2.2 Side effects of medications
3.3 Growth potential analysis
3.4 Pipeline assessment
3.5 Regulatory landscape
3.6 Porter's analysis
- 3.6.1 Supplier power
- 3.6.2 Buyer power
- 3.6.3 Threat of new entrants
- 3.6.4 Threat of substitutes
- 3.6.5 Industry rivalry
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategic dashboard

Chapter 5 Market Estimates and Forecast, By Drug Type, 2018 - 2032 ($ Mn)

5.1 Key trends
5.2 Antibiotics
- 5.2.1 Cephalosporins
- 5.2.2 Penicillins
- 5.2.3 Fluoroquinolones
- 5.2.4 Imidazole
- 5.2.5 Other antibiotics
5.3 Antifungals
5.4 Corticosteroids
5.5 Cleaning agents
5.6 Other drug types

Chapter 6 Market Estimates and Forecast, By Animal Type, 2018 - 2032 ($ Mn)

6.1 Key trends
6.2 Dogs
6.3 Cats
6.4 Horses
6.5 Other animal types

Chapter 7 Market Estimates and Forecast, By Medication Type, 2018 - 2032 ($ Mn)

7.1 Key trends
7.2 OTC
7.3 Prescription

Chapter 8 Market Estimates and Forecast, By Mode of Administration, 2018 - 2032 ($ Mn)

8.1 Key trends
8.2 Otic
8.3 Oral
8.4 Parenteral
8.5 Topical

Chapter 9 Market Estimates and Forecast, By Disease Type, 2018 - 2032 ($ Mn)

9.1 Key trends
9.2 Otitis externa
9.3 Otitis media
9.4 Otitis interna

Chapter 10 Market Estimates and Forecast, By Distribution Channel, 2018 - 2032 ($ Mn)

10.1 Key trends
10.2 Veterinary hospital pharmacies
10.3 Drug stores
10.4 Pet specialty stores
10.5 E-commerce

Chapter 11 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

11.1 Key trends, by region
11.2 North America
- 11.2.1 U.S.
- 11.2.2 Canada
11.3 Europe
- 11.3.1 Germany
- 11.3.2 UK
- 11.3.3 France
- 11.3.4 Spain
- 11.3.5 Italy
- 11.3.6 Rest of Europe
11.4 Asia Pacific
- 11.4.1 Japan
- 11.4.2 China
- 11.4.3 India
- 11.4.4 Australia
- 11.4.5 Rest of Asia Pacific
11.5 Latin America
- 11.5.1 Brazil
- 11.5.2 Mexico
- 11.5.3 Rest of Latin America
11.6 Middle East and Africa
- 11.6.1 South Africa
- 11.6.2 Saudi Arabia
- 11.6.3 Rest of Middle East and Africa